General Information of Drug (ID: DM15VBJ)

Drug Name
Artemisone Drug Info
Synonyms
Artemifone; Artemisone, Medicines For Malaria Venture; MMV-00/1007; Artemisinin derviative, Bayer/WHO/Hong Kong University; Artemisone, Bayer/WHO/Hong Kong University; Semi-synthetic endoperoxide, Bayer/WHO/Hong Kong University
Indication
Disease Entry ICD 11 Status REF
Malaria 1F40-1F45 Phase 2/3 [1]
Cross-matching ID
PubChem CID
11531457
CAS Number
CAS 255730-18-8
TTD Drug ID
DM15VBJ

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arteether DMQLX7O Malaria 1F40-1F45 Approved [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Beta-hematin formation (BHF) TT9X7H4 NOUNIPROTAC Modulator [2]

References

1 ClinicalTrials.gov (NCT00936767) Artemisone for the Treatment of Uncomplicated Falciparum Malaria in Western Cambodia. U.S. National Institutes of Health.
2 Anticancer Properties of Distinct Antimalarial Drug Classes. PLoS One. 2013; 8(12): e82962.
3 Lack of association of the S769N mutation in Plasmodium falciparum SERCA (PfATP6) with resistance to artemisinins. Antimicrob Agents Chemother. 2012 May;56(5):2546-52.